UTES vs. BBC
Compare and contrast key facts about Virtus Reaves Utilities ETF (UTES) and Virtus LifeSci Biotech Clinical Trials ETF (BBC).
UTES and BBC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. UTES is an actively managed fund by Virtus Investment Partners. It was launched on Sep 23, 2015. BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014.
Performance
UTES vs. BBC - Performance Comparison
Loading graphics...
UTES vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UTES Virtus Reaves Utilities ETF | 1.60% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
Returns By Period
In the year-to-date period, UTES achieves a 1.60% return, which is significantly lower than BBC's 7.95% return. Over the past 10 years, UTES has outperformed BBC with an annualized return of 12.83%, while BBC has yielded a comparatively lower 8.41% annualized return.
UTES
- 1D
- 0.11%
- 1M
- -6.27%
- YTD
- 1.60%
- 6M
- -3.38%
- 1Y
- 25.54%
- 3Y*
- 22.73%
- 5Y*
- 16.38%
- 10Y*
- 12.83%
BBC
- 1D
- 7.67%
- 1M
- -1.98%
- YTD
- 7.95%
- 6M
- 55.07%
- 1Y
- 141.32%
- 3Y*
- 25.09%
- 5Y*
- -3.63%
- 10Y*
- 8.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
UTES vs. BBC - Expense Ratio Comparison
UTES has a 0.49% expense ratio, which is lower than BBC's 0.79% expense ratio.
Return for Risk
UTES vs. BBC — Risk / Return Rank
UTES
BBC
UTES vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus Reaves Utilities ETF (UTES) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTES | BBC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.13 | 3.52 | -2.39 |
Sortino ratioReturn per unit of downside risk | 1.56 | 3.86 | -2.29 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.47 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 1.88 | 6.54 | -4.66 |
Martin ratioReturn relative to average drawdown | 4.68 | 25.10 | -20.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| UTES | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.13 | 3.52 | -2.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.81 | -0.09 | +0.90 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.22 | +0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.72 | 0.12 | +0.60 |
Correlation
The correlation between UTES and BBC is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
UTES vs. BBC - Dividend Comparison
UTES's dividend yield for the trailing twelve months is around 1.47%, less than BBC's 1.57% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UTES Virtus Reaves Utilities ETF | 1.47% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
Drawdowns
UTES vs. BBC - Drawdown Comparison
The maximum UTES drawdown since its inception was -35.39%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for UTES and BBC.
Loading graphics...
Drawdown Indicators
| UTES | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.39% | -76.85% | +41.46% |
Max Drawdown (1Y)Largest decline over 1 year | -13.88% | -18.03% | +4.15% |
Max Drawdown (5Y)Largest decline over 5 years | -20.40% | -72.58% | +52.18% |
Max Drawdown (10Y)Largest decline over 10 years | -35.39% | -76.85% | +41.46% |
Current DrawdownCurrent decline from peak | -7.89% | -30.71% | +22.82% |
Average DrawdownAverage peak-to-trough decline | -5.51% | -37.30% | +31.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.59% | 5.05% | +0.54% |
Volatility
UTES vs. BBC - Volatility Comparison
The current volatility for Virtus Reaves Utilities ETF (UTES) is 8.04%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 13.21%. This indicates that UTES experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| UTES | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.04% | 13.21% | -5.17% |
Volatility (6M)Calculated over the trailing 6-month period | 16.26% | 26.93% | -10.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.79% | 40.92% | -18.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.28% | 39.30% | -19.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.03% | 37.86% | -17.83% |